ArticleFrontiers in immunology2018
Beyond Type 1 Regulatory T Cells: Co-expression of LAG3 and CD49b in IL-10-Producing T Cell Lineages.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.
- In or out of control: Modulating regulatory T cell homeostasis and function with immune checkpoint pathways.Frontiers in immunology · 2022Pooled it
- Depletion of LAG-3Clinical pharmacology and therapeutics · 2021Trial
- Reduced IL-10 production by FoxP3+IL-10+ Treg cells is partially compensated by complosome-associated induction of regulatory FoxP3-IL-10+ T cells in allergic eosinophilic asthma.Clinical and experimental immunology · 2026Article
- miR-9-5p alleviates the development of abdominal aortic aneurysm by regulating the differentiation of CD4Turkish journal of biology = Turk biyoloji dergisi · 2025Article
- A Novel Subset of Regulatory T Cells Induced by B Cells Alleviate the Severity of Immunological Diseases.Clinical reviews in allergy & immunology · 2024Review
- Review
- Quantitative analysis of Tr1 lymphocytes in patients with type 2 diabetes mellitus.Journal of endocrinological investigation · 2024Article
- Integrin α2 in the microenvironment and the tumor compartment of digestive (gastrointestinal) cancers: emerging regulators and therapeutic opportunities.Frontiers in oncology · 2024Review
- Adaptive plasticity of natural interleukin-35-induced regulatory T cells (Tr35) that are required for T-cell immune regulation.Theranostics · 2024Article
- STING activation promotes autologous type I interferon-dependent development of type 1 regulatory T cells during malaria.The Journal of clinical investigation · 2023Article
- LAG-3 as the third checkpoint inhibitor.Nature immunology · 2023Review
- Neuroinflammation: Extinguishing a blaze of T cells.Immunological reviews · 2022Review
- Smoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis.Cancer research communications · 2022Article
- The Role of T Lymphocytes in Cutaneous Scarring.Advances in wound care · 2022Review
- Glutaminolysis is required in maintaining immune regulatory functions in B cells.Mucosal immunology · 2022Article
- Roles of type 1 regulatory T (Tr1) cells in allergen-specific immunotherapy.Frontiers in allergy · 2022Review
- High Serum Vitamin D Concentrations, InducedFrontiers in immunology · 2022Article
- Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteins.Scientific reports · 2021Article
- Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.International journal of molecular sciences · 2021Article
- hPMSCs inhibit the expression of PD-1 in CD4Stem cell research & therapy · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Weishan HuangDepartment of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, United States.
Sabrina SoloukiDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Chavez CarterDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Song-Guo ZhengDepartment of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey, PA, United States.
Avery AugustDepartment of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, United States.
Cornell University · USLouisiana State University · USPennsylvania State University · US
Funding
Protein CoreP30GM110760 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI KOUSOULAS, KONSTANTIN G · 2014 to 2018
$5.6MTherapeutic immunoregulation mediated by TGF-??-induced iTregs in autoimmune arthR01AR059103 · NIAMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JARJOUR, WAEL N · 2010 to 2020
$3.9MRegulation of IL10 production in CD8+ T cells during Flu infection by tyrosine kinase ItkR01AI138570 · NIAID · CORNELL UNIVERSITY · PI AUGUST, AVERY · 2018 to 2022
$2.1MItk mediated tuning of CD8+ memory T cell developmentR01AI120701 · NIAID · CORNELL UNIVERSITY · PI AUGUST, AVERY · 2016 to 2019
$1.5MA novel murine model of allergic airway inflammation.R21AI138497 · NIAID · CORNELL UNIVERSITY · PI AUGUST, AVERY, HUANG, WEISHAN · 2018 to 2019
$443kItk signaling and Type 1 regulatory T cell differentiation and function in allergic airway inflammationR21AI129422 · NIAID · CORNELL UNIVERSITY · PI AUGUST, AVERY, HUANG, WEISHAN · 2018 to 2019
$431kControlling Th17 cells and responses in airway inflammation by tyrosine kinase ItkR21AI126814 · NIAID · CORNELL UNIVERSITY · PI AUGUST, AVERY · 2016 to 2017
$426kGCN2 signaling in pathogenic and regulatory T cell development in allergic airway inflammationR21AI137822 · NIAID · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI HUANG, WEISHAN · 2018 to 2019
$407kNIAID NIH HHS R01 AI120701NIAID NIH HHS R01 AI138570NIAID NIH HHS R21 AI126814NIAID NIH HHS R21 AI129422NIAID NIH HHS R21 AI137822NIAID NIH HHS R21 AI138497NIAMS NIH HHS R01 AR059103NIGMS NIH HHS P30 GM110760
Abstract
Type 1 regulatory CD4
Indexed as
AnimalsAntigens, CDBiomarkersCD8-Positive T-LymphocytesCell DifferentiationCell LineageCells, CulturedForkhead Transcription FactorsHumansImmune ToleranceIntegrin alpha2Interleukin-10Lymphocyte Activation Gene 3 ProteinMiceMice, Inbred C57BLMice, KnockoutAntigens, CDBiomarkersForkhead Transcription FactorsFoxp3 protein, mouseIntegrin alpha2Interleukin-10Lymphocyte Activation Gene 3 Proteinfarmer's lung diseaseFoxp3house dust miteIL-10influenza infectionlung inflammationparasitic infectionT cell
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.